These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32599662)

  • 1. Ethnic and socio-economic disparities in prostate cancer screening: lessons from New Zealand.
    Matti B; Lyndon M; Zargar-Shoshtari K
    BJU Int; 2021 Dec; 128 Suppl 3():11-17. PubMed ID: 32599662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
    Obertová Z; Scott N; Brown C; Hodgson F; Stewart A; Holmes M; Lawrenson R
    BMC Fam Pract; 2014 Aug; 15():145. PubMed ID: 25154420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of non-structured PSA testing on prostate cancer-specific mortality on New Zealand Māori men.
    Matti B; Nguyen CH; Lyndon MP; Zargar-Shoshtari K
    World J Urol; 2024 Oct; 42(1):558. PubMed ID: 39361189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Maori and Pacific Islander men present with more advanced prostate cancer than European New Zealand men? An analysis of 486 men undergoing biopsy in Auckland.
    Pokorny MR; Scott DJ
    BJU Int; 2011 Apr; 107 Suppl 3():27-32. PubMed ID: 21492373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum prostate-specific antigen levels and public health implications in three New Zealand ethnic groups: European, Maori, and Pacific Island men.
    Gray M; Borman B; Crampton P; Weinstein P; Wright C; Nacey J
    N Z Med J; 2005 Feb; 118(1209):U1295. PubMed ID: 15711628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inequalities between Māori and non-Māori men with prostate cancer in Aotearoa New Zealand.
    Egan R; Lawrenson R; Kidd J; Cassim S; Black S; Blundell R; Bateman J; Broughton JR
    N Z Med J; 2020 Sep; 133(1521):69-76. PubMed ID: 32994638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival disparities between Māori and non-Māori men with prostate cancer in New Zealand.
    Obertová Z; Scott N; Brown C; Stewart A; Lawrenson R
    BJU Int; 2015 Apr; 115 Suppl 5():24-30. PubMed ID: 25124231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving survival disparities in cervical cancer between Māori and non-Māori women in New Zealand: a national retrospective cohort study.
    McLeod M; Harris R; Purdie G; Cormack D; Robson B; Sykes P; Crengle S; Iupati D; Walker N
    Aust N Z J Public Health; 2010 Apr; 34(2):193-9. PubMed ID: 23331365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment modalities for Māori and New Zealand European men with localised prostate cancer.
    Obertová Z; Lawrenson R; Scott N; Holmes M; Brown C; Lao C; Tyrie L; Gilling P
    Int J Clin Oncol; 2015 Aug; 20(4):814-20. PubMed ID: 25557325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rural-Urban Differences in Prostate-Specific Antigen (PSA) Screening and Its Outcomes in New Zealand.
    Obertová Z; Hodgson F; Scott-Jones J; Brown C; Lawrenson R
    J Rural Health; 2016; 32(1):56-62. PubMed ID: 26174590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Māori ethnicity misclassification on cervical screening coverage.
    Sandiford P; Salvetto M; Bramley D; Wong S; Johnson L
    N Z Med J; 2013 Apr; 126(1372):55-65. PubMed ID: 23793178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnic differences in acute hospitalisations for otitis media and elective hospitalisations for ventilation tubes in New Zealand children aged 0-14 years.
    McCallum J; Craig L; Whittaker I; Baxter J
    N Z Med J; 2015 Jun; 128(1416):10-20. PubMed ID: 26117671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunistic prostate cancer screening: A population-based analysis.
    Matti B; Zargar-Shoshtari K
    Urol Oncol; 2020 May; 38(5):393-400. PubMed ID: 31952998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs of identifying undiagnosed prostate cancer in asymptomatic men in New Zealand general practice.
    Lao C; Brown C; Obertová Z; Edlin R; Rouse P; Hodgson F; Holmes M; Gilling P; Lawrenson R
    Fam Pract; 2013 Dec; 30(6):641-7. PubMed ID: 24055993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental exposure to trace elements and prostate cancer in three New Zealand ethnic groups.
    Gray MA; Centeno JA; Slaney DP; Ejnik JW; Todorov T; Nacey JN
    Int J Environ Res Public Health; 2005 Dec; 2(3-4):374-84. PubMed ID: 16819092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing trends in indigenous inequalities in mortality: lessons from New Zealand.
    Tobias M; Blakely T; Matheson D; Rasanathan K; Atkinson J
    Int J Epidemiol; 2009 Dec; 38(6):1711-22. PubMed ID: 19332501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.
    Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ
    Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in prostate cancer survival in New Zealand: a national study.
    Sneyd MJ
    Cancer Causes Control; 2008 Nov; 19(9):993-9. PubMed ID: 18478341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer--are ethnic minorities disadvantaged?
    Lamb DS; Bupha-Intr O; Bethwaite P; Murray J; Nacey J; Russell G; Delahunt B
    Anticancer Res; 2008; 28(6B):3891-5. PubMed ID: 19192646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.